Thrombosis Risk Rises in Women With Myeloproliferative Disorders

Elsevier Global Medical News. 2010 Dec 20, H Splete

ORLANDO (EGMN) - Thrombosis was significantly more prevalent in women, compared with men, in a review of data from 270 adults with JAK2 V617-F-positive myeloproliferative disorder, according to a poster at the annual meeting of the American Society of Hematology. Vascular complications were identified in 29% of women vs. 18% of men in a cohort of patients seen at the center for myeloproliferative disorders of Johns Hopkins University in Baltimore, said Dr. Brady L. Stein of Northwestern University...

NOT A MEMBER?

Registration is FREE

  • Up-to-date oncology news
  • Journal article summaries
  • Commentaries and interviews
  • Drug and interactions database
  • Chemotherapy regimens
  • Daily e-newsletters

 

Meet Our Experts

Meet our Advisory and Editorial Boards comprised of physician editors and world-renowned experts.

Editors' Choice

Everolimus Plus Tamoxifen Improves Survival in Metastatic Breast Cancer

Cancer Type

  • Bladder
  • Bone
  • Breast
  • Breast (ER-Positive)
  • CNS/Brain
  • Colon and Rectum
  • Endocrine System
  • Esophagus
  • GYN (Non-Ovary)
  • GYN (Ovary)
  • Head and Neck
  • Hodgkin's Lymphoma
  • Kidney (Renal Cell)
  • Leukemia
  • Liver and Bile Duct
  • Lung
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • Myeloproliferative Diseases
  • Non-Hodgkin's Lymphoma
  • Pancreas
  • Pediatric Cancers
  • Prostate
  • Rare Cancers
  • Skin
  • Soft-Tissue Sarcoma
  • Stomach
  • Testicle
  • Forgot your password?
    Not a member? Free registration